The role of p53 family tumor suppressors in mediating response to aurora kinase inhibition in triple-negative breast cancer

被引：0
|
作者：
Diamond, J. R. [1 ]
Tan, A. C. [1 ]
Ionkina, A. A. [1 ]
Newton, T. P. [1 ]
Pitts, T. M. [1 ]
Eckhardt, S. G. [1 ]
Tentler, J. J. [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P2-09-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-06
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer
    Ionkina, Anastasia A.
    Tentler, John J.
    Kim, Jihye
    Capasso, Anna
    Pitts, Todd M.
    Ryall, Karen A.
    Howison, Rebekah R.
    Kabos, Peter
    Sartorius, Carol A.
    Tan, Aik Choon
    Eckhardt, S. Gail
    Diamond, Jennifer R.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [42] Novel synergy of radiosensitizer prodrug IPdR with Aurora kinase inhibitors in triple-negative breast cancer
    Rampurwala, Murtuza M.
    Choudhary, Alka
    Burkard, Mark E.
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo
    Dibra, Denada
    Xiong, Shunbin
    Moyer, Sydney M.
    El-Naggar, Adel K.
    Qi, Yuan
    Su, Xiaoping
    Kong, Elisabeth K.
    Korkut, Anil
    Lozano, Guillermina
    SCIENCE ADVANCES, 2024, 10 (07)
  • [44] Effect of family tumor history on survival of patients with triple-negative breast cancer
    Ozgan, A. Y.
    Turna, Z. H.
    Biricik, F. S.
    Ozturk, M. A.
    Tural, D.
    Ozgurluoglu, M.
    Mandel, N.
    Serdengecti, S.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 91 - 91
  • [45] Hotspot p53 mutations correlate with increased expression of stem cell markers in triple-negative breast cancer
    El-Dana, Fouad
    Yuan, Bin
    Ly, Stanley
    Anand, Vivek
    Battula, Venkata Lokesh
    CANCER RESEARCH, 2021, 81 (04)
  • [46] ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function
    Bado, Igor
    Nikolos, Fotis
    Rajapaksa, Gayani
    Gustafsson, Jan-Ake
    Thomas, Christoforos
    ONCOTARGET, 2016, 7 (12) : 13599 - 13611
  • [47] COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells
    Naoise C. Synnott
    David O’Connell
    John Crown
    Michael J. Duffy
    Breast Cancer Research and Treatment, 2020, 179 : 47 - 56
  • [48] The prognostic relevance of p53 and Ki-67 to chemotherapy sensitivity and prognosis in triple-negative breast cancer
    Zhang, Guojing
    Shi, Zhongyi
    Liu, Lina
    Yuan, Heqing
    Pan, Zheng
    Li, Wenxu
    Tao, Yu
    Huang, Zhaoming
    Huang, Xiaoying
    Lin, Chao
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (02) : 1082 - 1087
  • [49] p53 status identifies triple-negative breast cancer patients who do not respond to adjuvant chemotherapy
    Coradini, Danila
    Biganzoli, Elia
    Ardoino, Ilaria
    Ambrogi, Federico
    Boracchi, Patrizia
    Demicheli, Romano
    Daidone, Maria Grazia
    Moliterni, Angela
    BREAST, 2015, 24 (03): : 294 - 297
  • [50] COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells
    Synnott, Naoise C.
    O'Connell, David
    Crown, John
    Duffy, Michael J.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (01) : 47 - 56
12345